20 May 2013
Keywords: cocensys, novel, migraine, drug, effective, phase, ii
Article | 25 February 1998
CoCensys has reported encouraging data from a placebo-controlled,double-blind Phase II clinical trial of its lead product ganaxolone for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 February 1998
26 February 1998
17 May 2013
© 2013 thepharmaletter.com